Dr. Andruska is a board-certified neurologist and fellowship-trained movement disorders specialist. She believes in a
patient-centered approach to the treatment of all movement disorders. She also has expertise in the use of focused ultrasound,
deep brain stimulation, and botulinum toxin injections for Parkinson’s disease, essential tremor, dystonia, and more.
She attended the University of Texas at Austin, where she received her undergraduate degree in biology. After graduation she
worked as a genetics researcher at the Baylor College of Medicine in Houston, Texas. In this role, she researched the genetic
mechanisms of pediatric cancer syndromes. She then attended the University of Minnesota for the National Institute of
Health’s Medical Scientist Training Program, earning both an MD and a PhD. She received a competitive Kirschstein
predoctoral fellowship to support her PhD research in the laboratory of Dr. Harry Orr. Her doctoral research focused on the
biochemistry of inherited neurodegenerative disease, specifically spinocerebellar ataxia type 1 (SCA1).
Dr. Andruska completed her neurology residency at Washington University in Saint Louis, where she also served as its first
Chief Resident of Education. She was the recipient of the Irwin Levy Prize for Teaching and the Abdullah M. Nassief Award
for Neurology. While at Washington University, she researched the molecular and genetic mechanisms of Parkinson disease.
After residency, she completed her sub-specialty movement disorders fellowship at Stanford University. Before CMDC, she
was the Medical Director of the Parkinson’s Institute and Clinical Center.